Federal award
QUIDELORTHO SALES COMPANY, LLC
HT941024P0004
Contract
Obligated and Ceiling
- Obligated (net)
- $227,595.26
- Ceiling (potential value, not spending)
- $475,370.41
- Current value
- $278,027.05
- Gross positive obligations
- $227,595.26
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT941024P0004
- Award type code
- B
- Actions
- 9 · Oct 17, 2023 to Mar 5, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 5, 2026 | FY2026 | P00008 | B | $8,960.18 | — |
| Jan 14, 2026 | FY2026 | P00007 | B | $39,279.71 | — |
| Sep 9, 2025 | FY2025 | P00006 | V | $0.00 | — |
| Mar 6, 2025 | FY2025 | P00005 | B | $0.00 | — |
| Nov 12, 2024 | FY2025 | P00004 | C | $92,767.68 | — |
| Sep 17, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Feb 12, 2024 | FY2024 | P00002 | B | $49,275.98 | — |
| Jan 4, 2024 | FY2024 | P00001 | B | $37,311.71 | — |
| Oct 17, 2023 | FY2024 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.